FDA classes the compounded GLP-1 recall as Class II
PIX11 reports the FDA rates the risk from the recalled compounded GLP-1 drugs as temporary or reversible, with little chance of serious harm.
Recap by typeshit. Post by @pix11news on Instagram.
PIX11 reports the FDA rates the risk from the recalled compounded GLP-1 drugs as temporary or reversible, with little chance of serious harm.
Recap by typeshit. Post by @pix11news on Instagram.
Peptide talk is everywhere from YouTube to Reddit. CNBC looks at what is actually known about their safety.
The post warns that people in their 50s and 60s may blame vision changes on age or screens, when researchers have tied the drug in Ozempic to a rare cause of sudden sight loss.
Facial fat loss during GLP-1 weight loss can mean hollowing, flatter cheeks and looser skin, and Dr. Makkani says creams won't solve all of it.
Health authorities are warning people off unregulated peptides as emergency departments report a rise in severe allergic reactions.
PIX11 reports the recall covers 23 compounded GLP-1 vials because there is no assurance they are sterile. Check the list if you use compounded shots.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Loading…